Compound ID | 1960
Class: Beta-lactam (monobactam)
Spectrum of activity: | Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) with high affinity for PBP 3 and mild affinity for PBP 1a and interferes with bacterial cell wall integrity and synthesis. It is active against gram-negative bacteria including many metallo-beta-lactamase producing strains. |
Description: | Synthetic monobactam. Intravenous application. Aztreonam lysine is used as a nebuliser solution for suppressive therapy of chronic pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis. Aztreonam is studied in combination with the beta-lactamase inhibitor avibactam |
Year first mentioned: | 1979 |
Development status: | Approved, off-patent |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5742832 |
Guide to Pharmacology: | aztreonam |
Citations: |
|